Over-activation of PI3K-AKT signaling pathway can regulate apoptosis by inhibiting pro-apoptotic protein Bcl2-associated agonist of cell death (Bad) [13], resulting in tumor cell survival and drug resistance [14, 15]. This evidence concerns the gene AKT1 and neoplasm.